Empagliflozin Eyed for Outpatient Chronic Hyponatremia Uncategorized / June 21, 2022 The SGLT2 inhibitor increased sodium and reduced neurocognitive dysfunction in patients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis. Medscape Medical News